Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the "rubber effect".
Panayiotis D ZiakasIrene S KourbetiLoukia S PoulouGeorgios S VlachogeorgosEleftherios MylonakisPublished in: PloS one (2018)
DOACs have been increasing their share year-over-year, but adoption varies across specialties. In prevalent areas for stroke and atrial fibrillation, prescription dispersion magnifies, and this may signify a rapid adoption by top providers.
Keyphrases
- direct oral anticoagulants
- atrial fibrillation
- venous thromboembolism
- oral anticoagulants
- electronic health record
- catheter ablation
- left atrial
- left atrial appendage
- primary care
- heart failure
- percutaneous coronary intervention
- emergency department
- adverse drug
- healthcare
- acute coronary syndrome
- loop mediated isothermal amplification
- coronary artery disease